Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Two Anti-HIV Treatment Strategies in Resource-Limited South African Communities

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* HIV-1 infected~* Current severe CDC Category B AIDS-defining illness (with the exception of a single episode of bacterial sepsis or a single episode of zoster), OR history of a severe CDC Category B or C AIDS-defining illness, OR one CD4 count less than 350 cells/mm3 within 6 months prior to study entry~* Antiretroviral naive. A participant who previously received 6 weeks or less of post-exposure prophylaxis or short course therapy for the prevention of mother-to-child transmission are not excluded. More information on this criterion can be found in the protocol.~* Willing to use acceptable forms of contraception~* Parent or guardian willing to provide informed consent, if applicable~Exclusion Criteria:~* Current newly diagnosed CDC Category C AIDS-defining opportunistic infection or condition requiring acute therapy at the time of study entry. More information on this criterion can be found in the protocol.~* Therapy with agents with significant systemic myelosuppressive, neurotoxic, pancreatotoxic, hepatotoxic, or cytotoxic potential within 30 days prior to study entry~* Require certain medications~* Current alcohol or substance abuse that, in the opinion of the investigator, may interfere with the study~* Uncontrolled diarrhea (more than 6 stools per day for 7 consecutive days) within 30 days prior to study entry~* Diagnosis of or suspected acute hepatitis within 30 days prior to study entry~* Signs or symptoms of bilateral peripheral neuropathy of Grade 2 or greater at screening~* Inability to tolerate oral medication~* Any other clinical condition that, in the opinion of the investigator, may interfere with the study~* In the first trimester of pregnancy

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- A (Type: ACTIVE_COMPARATOR): Study-specified Antiretroviral regimen under care of HIV-trained medical doctor
- B (Type: ACTIVE_COMPARATOR): Study-specified Antiretroviral regimen under care of HIV-trained primary care nurse

Based on this trial design, predict the completion outcome and termination type (if applicable).